Christopher Caponetti Recent News
UPDATE: Morgan Stanley Reiterates on Mallinckrodt Following Encouraging F1Q Results
UPDATE: Morgan Stanley Initiates Coverage on "Stand Out" Mallinckrodt
UPDATE: Morgan Stanley Upgrades Valeant Pharmaceuticals On Durability of Pricing Growth
UPDATE: Morgan Stanley Downgrades Zoetis on Low Expectations for Catalysts in 2014